$1.21 (3.74%)

Volume: 38.269k

Closed: Dec 02, 2022

Hollow Logo Score: -3.975

Ekso Bionics Holdings Stock Forecast

$1.21 (3.74%)

Volume: 38.269k

Closed: Dec 02, 2022

Score Hollow Logo -3.975

Ekso Bionics Holdings Stock News NASDAQ:EKSO

Ekso Bionics (EKSO) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among W Read more

Ekso Bionics (EKSO) Reports Q1 Loss, Lags Revenue Estimates

09:35pm, Thursday, 28'th Apr 2022 Zacks Investment Research
Ekso Bionics (EKSO) delivered earnings and revenue surprises of 12.20% and 19.78%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock? Read more

Ekso Bionics Reports First Quarter 2022 Results

08:05pm, Thursday, 28'th Apr 2022 GlobeNewswire Inc.
RICHMOND, Calif., April 28, 2022 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, toda Read more

SARTORIUS (SARTF) Tops Q1 Earnings and Revenue Estimates

02:25pm, Thursday, 21'st Apr 2022 Zacks Investment Research
SARTORIUS (SARTF) delivered earnings and revenue surprises of 10.04% and 8.72%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock? Read more

Ekso Bionics to Report First Quarter 2022 Financial Results on April 28

12:03pm, Thursday, 21'st Apr 2022 GlobeNewswire Inc.
RICHMOND, Calif., April 21, 2022 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, toda Read more

Ekso Bionics (EKSO) Reports Q4 Loss, Tops Revenue Estimates

11:00pm, Thursday, 24'th Feb 2022 Zacks Investment Research
Ekso Bionics (EKSO) delivered earnings and revenue surprises of 8% and 1.90%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock? Read more

Ekso Bionics Holdings GAAP EPS of -$0.23, revenue of $4.1M

09:36pm, Thursday, 24'th Feb 2022 Seeking Alpha
Ekso Bionics Holdings press release (EKSO): Q4 GAAP EPS of -$0.23.Revenue of $4.1M (+82.2% Y/Y).Cash on hand at December 31, 2021 was $40.4 million, compared to $12.9 million at… Read more
RICHMOND, Calif., Feb. 17, 2022 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today announced that it will release financial and business results for the fourth quarter and full year 2021 after the close of trading on Thursday, February 24, 2022. Management will host a conference call beginning at 1:30 p.m. PT / 4:30 p.m. ET to discuss the financial results and recent business developments. Read more

Ekso Bionics'' CEO Jack Peurach steps down

09:05pm, Friday, 21'st Jan 2022 Seeking Alpha
Ekso Bionics (EKSO) said CEO Jack Peurach decided to leave the firm effective Jan. 21 to pursue other endeavors.Peurach also stepped down from EKSO''s board effective Jan. 21.Effective Jan Read more

Ekso Bionics Announces Leadership Transition

09:01pm, Friday, 21'st Jan 2022 GlobeNewswire Inc.
Board Member Steven Sherman to be Appointed CEO Read more

Ekso Bionics Holdings Inc Shares Near 52-Week Low - Market Mover

05:26am, Saturday, 15'th Jan 2022 Kwhen Finance
Ekso Bionics Holdings Inc (EKSO) shares closed today at 1.6% above its 52 week low of $2.49, giving the company a market cap of $32M. The stock is currently down 4.2% year-to-date, down 71.4% over the past 12 months, and down 95.9% over the past five years. This week, the Dow Jones Industrial Average fell 0.3%, and the S&P 500 fell 0.7%. Trading Activity Trading volume this week was 77.0% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.4. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought.The stock closed at 0.9% lower than its 5-day moving average, 8.2% lower than its 20-day moving average, and 31.3% lower than its 90-day moving average. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by -29.9% The company's stock price performance over the past 12 months lags the peer average by 211.1% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected] © 2020 Kwhen Inc. Read more
Ekso Bionics Holdings Inc (EKSO) shares closed 1.6% lower than its previous 52 week low, giving the company a market cap of $33M. The stock is currently up 0.8% year-to-date, down 61.4% over the past 12 months, and down 95.9% over the past five years. This week, the Dow Jones Industrial Average fell 0.3%, and the S&P 500 fell 1.9%. Trading Activity Trading volume this week was 68.8% lower than the 20-day average.Beta, a measure of the stock’s volatility relative to the overall market stands at 1.4. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by -111.9% The company's stock price performance over the past 12 months lags the peer average by 394.3% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected] © 2020 Kwhen Inc. Read more
Ekso Bionics <> estimates record Q4 revenues in the range of $3.9 million to $4.1 million vs Read more
RICHMOND, Calif., Jan. 04, 2022 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO), an industry leader in exoskeleton technology for medical and industrial use, today announced that mana Read more

Hot Stocks To Watch:

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE